EyePoint Pharmaceuticals Logo

EyePoint Pharmaceuticals

🇺🇸
EYPT
US30233G2093

EyePoint Pharmaceuticals is a US-based biopharmaceutical company specializing in innovative therapies for eye diseases. The company focuses on the development and commercialization of advanced drug delivery technologies designed to treat chronic retinal conditions.

Next Quarterly Earnings

Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 7, 2026

Stock Price

Frequently asked questions

When will EyePoint Pharmaceuticals report its next quarterly earnings?

EyePoint Pharmaceuticals is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did EyePoint Pharmaceuticals last report quarterly earnings?

EyePoint Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -1.09 USD.

How often has EyePoint Pharmaceuticals beaten expectations?

EyePoint Pharmaceuticals has beaten analyst EPS estimates in 0 of its last 5 evaluated quarters (beat rate: 0%).

How do I add the EyePoint Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.91
Actual:
Q2 2026
Missed
Estimate:-$0.98
Actual:-$1.09
Difference:-$0.11
Q1 2026
Missed
Estimate:-$0.81
Actual:-$0.99
Difference:-$0.18
Price reaction (1 day):-2.9 %
Price reaction (7 days):-2.3 %
Q4 2025
Missed
Estimate:-$0.75
Actual:-$0.81
Difference:-$0.06
Price reaction (1 day):-1.8 %
Price reaction (7 days):-18.6 %
Q2 2025
Missed
Estimate:-$0.77
Actual:-$0.85
Difference:-$0.08
Q1 2025
Missed
Estimate:-$0.80
Actual:-$0.85
Difference:-$0.05

Earnings statistics

Estimates vs. results

0/5
Quarters above estimates
0%
Beat rate
-8.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
EyePoint Pharmaceuticals
Ticker Symbol
EYPT
ISIN
US30233G2093
Country
🇺🇸
USA
Sector